Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2015, Article ID 635481, 4 pages
http://dx.doi.org/10.1155/2015/635481
Case Report

Keloidal Scleroderma: Case Report and Review

Department of Dermatology, University of Alabama at Birmingham, EFH 414, 1530 3rd Avenue S, Birmingham, AL 35294, USA

Received 9 September 2015; Revised 9 November 2015; Accepted 18 November 2015

Academic Editor: Jacek Cezary Szepietowski

Copyright © 2015 Sama Kassira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Labandeira, A. León-Mateos, J. M. Suárez-Peñaranda, M. T. Garea, and J. Toribio, “What is nodular-keloidal scleroderma?” Dermatology, vol. 207, no. 2, pp. 130–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Stadler, M. T. Fontana, A. P. B. Somacal, T. L. Skare, and E. Weingraber, “Systemic sclerosis with keloidal nodules,” Anais Brasileiros de Dermatologia, vol. 88, supplement 1, no. 6, pp. 75–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Zwischenberger and H. T. Jacobe, “A systematic review of morphea treatments and therapeutic algorithm,” Journal of the American Academy of Dermatology, vol. 65, no. 5, pp. 925–941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. F. H. J. van den Hoogen, A. M. T. Boerbooms, A. J. G. Swaak, J. J. Rasker, H. J. J. van Lier, and L. B. A. van de Putte, “Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial,” British Journal of Rheumatology, vol. 35, no. 4, pp. 364–372, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Pope, N. Bellamy, J. R. Seibold et al., “A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma,” Arthritis and Rheumatism, vol. 44, no. 6, pp. 1351–1358, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Melani, M. Caproni, C. Cardinali et al., “A case of nodular scleroderma,” The Journal of Dermatology, vol. 32, no. 12, pp. 1028–1031, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Mizutani, H. Taniguchi, T. Sakakura, and M. Shimizu, “Nodular scleroderma: focally increased tenascin expression differing from that in the surrounding scleroderma skin,” Journal of Dermatology, vol. 22, no. 4, pp. 267–271, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Santiago, D. O. de Castro Jr., C. A. Costa, E. S. Passos, and A. Paixão, “Keloidal scleroderma,” Clinical Rheumatology, vol. 23, no. 1, pp. 50–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Sasaki, K. Denpo, H. Ono, and H. Nakajima, “Nodular scleroderma in systemic sclerosis under D-penicillamine therapy,” The Journal of Dermatology, vol. 19, no. 12, pp. 968–971, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. E. N. Le, J. M. Junkins-Hopkins, N. S. Sherber, and F. M. Wigley, “Nodular/keloidal scleroderma: acquired collagenous nodules in systemic sclerosis,” The Journal of Rheumatology, vol. 39, no. 3, pp. 660–661, 2012. View at Publisher · View at Google Scholar · View at Scopus